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Abstract
The extracellular matrix is a diverse composition of glyco-
proteins and proteoglycans found in all cellular systems. The 
extracellular matrix, abundant in the mammalian central 
nervous system, is temporally and spatially regulated and is a 
dynamic “living” entity that is reshaped and redesigned on a 
continuous basis in response to changing needs. Some modi-
fications are adaptive and some are maladaptive. It is the mal-
adaptive responses that pose a significant threat to successful 
axonal regeneration and/or sprouting following traumatic and 
spinal cord injuries, and has been the focus of a myriad of re-
search laboratories for many years. This review focuses largely 
on the extracellular matrix component, chondroitin sulfate 
proteoglycans, with certain comparisons to heparan sulfate 
proteoglycans, which tend to serve opposite functions in the 
central nervous system. Although about equally as well char-
acterized as some of the other proteoglycans such as hyaluro-
nan and dermatan sulfate proteoglycan, chondroitin sulfate 
proteoglycans are the most widely researched and discussed 
proteoglycans in the field of axonal injury and regeneration. 
Four laboratories discuss various aspects of chondroitin sul-
fate proteoglycans and proteoglycans in general with respect 
to their structure and function (Beller and Snow), the recent 
discovery of specific chondroitin sulfate proteoglycan recep-
tors and what this may mean for increased advancements in 
the field (Shen), extracellular matrix degradation by matrix 
metalloproteinases, which sculpt and resculpt to provide sup-
port for outgrowth, synapse formation, and synapse stability 
(Phillips et al.), and the perilesion microenvironment with 
respect to immune system function in response to proteogly-
cans and central nervous system injuries (Jakeman et al.).
Introduction
Proteoglycans (PGs) were originally isolated from cartilage 
tissue in 1891 followed by the development of carbohydrate 
chemistry within the early 20th century, which lead to the 
elucidation of different carbohydrate chain structures as-
sociated with PGs. Throughout these early years, PGs were 
seen as scaffolding within the extracellular matrix (ECM), 
and were thought to merely provide “structural support”. 
In the later part of the century, these functions were joined 
by data indicating PGs also provide proper spacing for the 
function of trophic factors and their receptors, and that PGs 
may provide direct signals to regulate central nervous sys-
tem (CNS) function. Fast forward to 2014, where PGs are 
now known to be a prominent part of a regulatory matrix 
surrounding all cells, and are of particular interest for the 
CNS and peripheral nervous system (PNS) functions that 
include differentiation, cell migration, cell division, cell-cell 
recognition, receptor function, ionic balance, growth factor 
function, immune response regulation, and both inhibition 
and promotion of axon growth and guidance. 
In this review, four laboratories come together to discuss 
some of the “next generation understandings” of how PGs of 
the ECM function, and how their unique structures, func-
tions and dynamic interactions contribute to their roles in 
CNS injuries. Chondroitin sulfate proteoglycans (CSPGs) 
might be thought of in terms of cellular and molecular 
“traffic”… 
Attention – Construction Area
Beller and Snow begin by examining the most fundamental 
aspect of CSPGs –  their structure – taking a historical per-
spective on our understanding of CSPGs and linking this 
with key advances that have identified the importance of 
individual moieties of the large and highly complex CSPG 
family of molecules. Beller and Snow place particular em-
phasis on growth cone behaviors following injury and res-
toration of growth cone/axonal function through specific 
modifications of CSPG microdomains.
Caution – Heed the Traffic Lights
CSPGs are large, highly negatively charged molecules. 
Thus, they were often supposed to act solely by blocking 
the binding of matrix molecules to their cell surface recep-
tors non-specifically, i.e., via steric hindrance. While this is 
likely to be accurate in some cases, specific receptors were 
also thought to be possible, but the extensive glycosylation 
of CSPGs precluded a typical ligand-receptor interaction 
and challenged receptor identification. The quest to identify 
CSPG receptors has finally been realized, leading to a new 
understanding that CSPGs act through multiple receptor 
types, i.e., members of the LAR and NgR families, suggesting 
functional redundancy and the need to target the specific 
receptors present in a given region. Here, Shen et al. discuss 
the pathway to the identification of CSPG receptors, exam-
ining work from the laboratories of Flanagan, Coles, David, 
Giger and Li. Collectively, these data show that CSPGs have 
multiple mechanisms by which to inhibit axon growth. Such 
CSPG receptor characterizations are now seen as exciting 
roads to the development of specific therapies to promote 
axonal regeneration and recovery of function.
Slow – Demolition Zone
Important for repair following CNS injury are the processes 
Neuronal growth cones and 
regeneration: gridlock within the 
extracellular matrix
SPECIAL ISSUE
A discussion of the extracellular matrix as an axonal 
outgrowth regulator following central nervous system injury 
with emphasis on proteoglycan structure and function, 
receptors, and degradation, and related immune responses
“The Matrix is everywhere. It is all around us…What is the 
Matrix? Control.”
                        
From Morpheus in “The Matrix”, 1999
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of neuroplasticity and synapse formation. Although many 
researchers have taken advantage of a bacterial enzyme, chon-
droitinase ABC (Chase) to cleave CSPG sugar chains, leaving 
behind a less inhibitory CSPG protein core, thus far, this 
methodology is more useful as an experimental tool than as 
a clinical application, given issue with stability and adequate 
delivery. Phillips and colleagues discuss the sculpting and re-
organization of CSPGs through their natural degradation en-
zymes, the matrix metalloproteinases (MMPs). They discuss 
neuroplasticity and synaptogenesis by showing a wide variety 
of roles for MMPs during injury-induced neuroplasticity, il-
lustrating how models of CNS deafferentation can be used to 
identify time dependent enzyme function under conditions 
of reactive synaptogenesis, and by presenting novel MMP 
interactions that may further clarify their control of regenera-
tive processes. They present new studies showing how MMPs 
interact with immune molecules to mediate cellular responses 
in the local regenerative environment, and are regulated by 
novel binding partners in the brain ECM. 
Stand Back – Ambulance to the Rescue
The ECM is reasonably stable, albeit engaging in routine 
dynamic maintenance activities. However, once injured, the 
terrain at the injury site is dramatically changed, becoming 
disorganized, reactive, and a site of acute neuroinflamma-
tion. Glial cells become reactive, dramatically changing the 
nature of ECM components, now in an attempt to cordon 
off the insult for repair and to minimize damage. To make 
matters worse, such deleterious changes do not rapidly re-
solve as one sees in the periphery, but rather, remain elevated 
and thereby orchestrate the plethora of hallmarks charac-
teristic of chronic injury. Jakeman and colleagues review 
literature that characterizes the reactions of glial cells and 
changes in the perilesion border following contusive brain 
injury. They discuss strategies to modify the inhibitory per-
ilesion microenvironment without eliminating the protective 
functions of glial cell activation, much like the goals stated 
by Beller and Snow, who also seek to modify the inhibitory 
aspects of CSPGs, while leaving the beneficial components 
intact.  Clearly, minimal interference is a common goal.
New Roadway – Promoting Young Researchers in the 
Field of Spinal Cord Injury Research
Thus, in this Special Issue, we review past achievements in 
ECM and proteoglycan research addressing axonal injury 
and regeneration, and also celebrate new advances and excit-
ing potential for future discoveries in this arena. Dually, we 
also celebrate some of the young researchers who are driving 
the field forward. For each article, significant contributions 
have been provided by young researchers at all levels. Dr. 
Justin Beller is a postdoctoral fellow at The University of 
Kentucky, Spinal Cord and Brain Injury Research Center 
(SCoBIRC), with a strong background in CNS injury, neu-
ropharmacology, and regulatory sciences. From the Jakeman 
laboratory at Ohio State University’s Center for Brain and 
Spinal Cord Repair, Kent Williams, M.S., is a recent grad-
uate, and is interested in a technical position; and another 
graduate, Bryan Brautigam, M.S., is interested in a career in 
teaching. From the Phillips laboratory at Virginia Common-
wealth University’s Department of Anatomy and Neurobi-
ology, Julie Chen is in the process of completing her Ph.D., 
and Adele E. Doperalski, Ph.D., is a current Postdoctoral 
Fellow. Yingjie Shen, Ph.D., formerly a Postdoctoral Fellow 
with Dr. John Flanagan, is a newly appointed Assistant Pro-
fessor at Department of Neuroscience, Ohio State University. 
Each researcher is moving forward to become the backbone 
for advances made in the field of regeneration, in particular, 
examining the critical role played by the ECM in controlling 
the success and failure of regeneration and recovery of func-
tion. We salute these, and all young pioneers in the field, for 
whom we have high hopes of discovering treatments, thera-
pies, and cures for spinal cord and brain related injuries.
Addendum: Since the acceptance of this publication, Justin 
A. Beller, Ph.D., has taken a position at Bend Research, Inc., 
in Bend, OR; and Lyn Jakeman, Ph.D., has moved to Wash-
ington, DC to serve as the Program Director for the National 
Institutes of Health, National Institutes of Neurological Dis-
orders and Stroke (NIH/NINDS).
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